|
ISMRM 21st
Annual Meeting & Exhibition
○
20-26 April 2013
○
Salt Lake City, Utah, USA |
|
|
|
|
Monday, 22 April 2013 |
|
Cardiovascular (10:45-12:45) |
|
1271 -1292 |
CE & Non CE MRA |
|
1293 -1316 |
Vessel Wall & Coronary Angiography |
|
1317 -1325 |
Myocardial Perfusion |
|
1326 -1356 |
Flow Quantification |
|
1357 -1378 |
Myocardial Tissue Characterization |
|
1379 -1393 |
Cardiac
Microstructure & Function |
|
1394 -1426 |
CV Imaging Technology
& Methodology |
|
1427 -1446 |
CV Image Processing &
Other |
|
|
|
|
Young Investigator Award Presentations (14:15-16:15) |
|
Young Investigator Award
Presentations |
|
|
|
Diffusion & Perfusion (16:30-18:30) |
|
2044 -2076 |
Diffusion Acquisition |
|
2077 -2094 |
Diffusion: Noise, Artifacts & Phantoms |
|
2095 -2116 |
Diffusion: Pre-Clinical & Clinical Applications |
|
2117 -2143 |
Fibre PDF's & Tractography |
|
2144 -2193 |
Arterial Spin Labeling |
|
2194 -2226 |
Perfusion &
Permeability |
|
|
|
|
Tuesday, 23 April 2013 |
|
Neuro A (10:00-12:00) |
|
0884 -0894 |
Normal Developing Brain |
|
0895 -0925 |
High Resolution Pediatric CNS Imaging |
|
0926 -0954 |
High Resolution Brain Anatomy & Morphometry |
|
0955 -0989 |
Human Brain Tumors: Diagnosis & Response |
|
0990 -1013 |
Advanced Imaging for
Dementia |
|
1014 -1033 |
Movement Disorders &
Degeneration |
|
1034 -1077 |
Animal Models Other
Than Stroke |
|
|
|
|
Pulse Sequences & Reconstruction A (13:30-15:30) |
|
2351 -2395 |
Pulse Sequences & Applications |
|
2396 -2400 |
RF Pulse Design |
|
2401 -2420 |
Fat & Water: Methods & Evaluations |
|
2421 -2447 |
MR Elastography |
|
2448 -2479 |
Relaxometry |
|
2480 -2504 |
Susceptibility |
|
2505 -2525 |
Contrast Mechanism: From Exotic
to Clinical Applications |
|
2526 -2555 |
CEST, MT, APT |
|
|
|
|
Body (16:00-18:00) |
|
1447 -1479 |
Hyperpolarized Gases: Methods, Applications, & Hardware |
|
1480 -1501 |
Advances in Pulmonary
Imaging |
|
1502 -1539 |
Diabetes, Obesity & Hepatobiliary |
|
1540 -1581 |
Genitourinary MRI |
|
1582 -1591 |
Body - Other |
|
|
|
|
Molecular Imaging (16:00-18:00) |
|
1850 -1913 |
Molecular & Cellular Imaging |
|
1914 -1937 |
Hyperpolarized Contrast Agents |
|
|
|
|
Wednesday, 24 April 2013 |
|
Pulse Sequences & Reconstruction B
(10:00-12:00) |
|
2556 -2566 |
Artifacts & Correction |
|
2567 -2576 |
Artifacts &
Correction: Off-Resonance & Eddy Currents |
|
2577 -2591 |
Artifacts &
Correction: Motion |
|
2592 -2600 |
B1 Mapping |
|
2601 -2628 |
Compressed Sensing |
|
2629 -2661 |
Image Reconstruction:
Non-Cartesian & Parallel Imaging |
|
2662 -2686 |
Image Reconstruction
& Analysis |
|
2687 -2706 |
Advances in Image
Analysis |
|
|
|
|
Musculoskeletal (13:30-15:30) |
|
1592 -1618 |
Bone/Tendon/Ligament/Spine |
|
1619 -1648 |
Muscle |
|
1649 -1663 |
Cartilage |
|
1664 -1690 |
Technical/Misc. |
|
|
|
|
Engineering (13:30-15:30) |
|
2707 -2719 |
Gradients & Shimming |
|
2720 -2759 |
Arrays & Array Technology |
|
2760 -2768 |
Specialized Systems & Devices |
|
2769 -2771 |
Magnets |
|
2772 -2796 |
Novel RF Coils |
|
2797 -2802 |
High-Dielectric Materials in RF Imaging |
|
2803 -2807 |
RF Simulations |
|
2808 -2818 |
PET/MRI Systems
Engineering |
|
2819 -2842 |
Safety (Non-Contrast
Agent) |
|
|
|
|
Cancer (16:00-18:00) |
|
1691 -1702 |
Preclinical Cancer: Perfusion,
Permeability, & Oxygenation |
|
1703 -1715 |
Preclinical Cancer:
Response to Therapy |
|
1716 -1727 |
Preclinical Cancer:
Spectroscopy & Molecular |
|
1728 -1768 |
Cancer of Breast &
Body |
|
1769 -1801 |
Prostate |
|
|
|
|
Interventional (16:00-18:00) |
|
1802 -1821 |
Thermotherapy & Thermometry |
|
1822 -1832 |
MR-Guided Focused Ultrasound |
|
1833 -1838 |
Intravascular MR-Guided Interventions |
|
1839 -1843 |
MR-Guided Interventions From Head to Toe |
|
1844 -1849 |
Software & Hardware
for MR-Guided Interventions |
|
|
|
|
Thursday, 25 April 2013 |
|
MR Spectroscopy (10:30-12:30) |
|
1938 -1946 |
MRS of Neurological Disease |
|
1947 -1954 |
Human MRS: In Vivo & In Vitro |
|
1955 -1972 |
MRS & Metabolism |
|
1973 -1981 |
MRS of Animal Models |
|
1982 -1995 |
ESR & Multinuclear |
|
1996 -2001 |
MRS & Relaxation |
|
2002 -2029 |
Methodology of Spectroscopic
Localization & Imaging |
|
2030 -2043 |
Methodology of Spectroscopic Quantitation |
|
|
|
|
Functional MRI (10:30-12:30) |
|
2227 -2239 |
Functional Connectivity:
Acquisitions & Artifacts |
|
2240 -2245 |
Functional Connectivity:
Electrophysiological Correlates |
|
2246 -2261 |
Functional Connectivity Analysis |
|
2262 -2274 |
Functional Connectivity:
Biomarkers |
|
2275 -2284 |
fMRI Acquisition: Methods &
Protocols |
|
2285 -2297 |
fMRI: Analysis of Activation |
|
2298 -2326 |
Animal fMRI Studies |
|
2327 -2350 |
Human fMRI Studies |
|
|
|
|
Neuro B (13:30-15:30) |
|
1078 -1110 |
Multiple Sclerosis &
Deteriorating Diseases |
|
1111 -1126 |
Spinal Cord |
|
1127 -1151 |
Neurovascular Disease - Clinical |
|
1152 -1181 |
fMRI of Brain Disorders |
|
1182 -1207 |
Imaging of
Psychiatric Disorders |
|
1208 -1235 |
Head & Neck |
|
1236 -1254 |
Novel Neuroimaging Methods |
| 1255 -1270 |
Manganese Enhanced
MRI |
|
| |